Main Topics

CELLULAR BIOLOGY OF ASTHMA

  • The cellular inflammatory component and cytokines
  • Novel developments in Th1, Th2 and Th17 effector cells
  • Manipulation of Th1 effector molecules in allergic asthma
  • New insights into eosinophils
  • The airway epithelium
  • The airway wall remodeling in asthma
  • The role of distal airways in asthma
  • Cellular and molecular mechanisms in airway remodeling
  • Vascular remodeling
  • Clinical impact of airway remodeling in asthma
  • Airway remodeling and immunoregulation
  • IgE in extrinsic and intrinsic asthma
  • Dendritic cells and asthma
  • Smooth muscle cells as the target of inflammation
  • Asthma: phenotypes, mechanisms
  • Novel developments in immunoregulation in asthma

ALLERGIC INFLAMMATION

  • Chemokines and asthma
  • The role of Th2 cells in allergy and asthma
  • Inflammation in asthma
  • Role of biomarkers in asthma
  • Exhaled nitric oxide and other gases
  • Nitric oxide: a marker of inflammation in asthma
  • Induced sputum
  • Markers in exhaled condensates

GENETICS OF ASTHMA

ASTHMA: DIFFERENT FACES AND DIFFERENT PHENOTYPES

ASTHMA EXACERBATIONS

  • Etiology of asthma exacerbations
  • Epidemiology and mechanisms of asthma exacerbations
  • Clinical models of asthma exacerbation
  • Viral infections in airway remodeling
  • Mechanisms of virus induced interferons & pro-inflammatory cytokines
  • Role of exacerbations in the pathogenesis of severe asthma

EPIDEMIOLOGY OF ASTHMA

ASTHMA GUIDELINES

EDUCATION AND DELIVERY OF CARE

ASTHMA IN THE ELDERLY

ASTHMA AND RESPIRATORY INFECTIONS

NEW THERAPIES FOR ASTHMA AND ALLERGIES

  • Anti-IgE therapy
  • Anti-IL4 and IL5 therapies
  • Allergen peptide immunotherapy
  • Allergen-specific immunotherapy
  • Immunomodulatory therapy in asthma
  • Application of pigmentary fractions of allergens in specific therapy of pollen asthma
  • Role of allergy in asthma
  • Multiallergen immunotherapy for rhinitis and asthma
  • Aspirin-induced asthma
  • Current and future treatments in asthma
  • Perspectives of gene therapy and asthma
  • Pharmacogenetics of β-agonist therapy of asthma
  • Cellular therapy for asthma

SPECIFIC IMMUNOTHERAPY IN ASTHMA

  • Mechanism of immunotherapy: an update
  • Immunotherapy in the prevention of asthma
  • Sublingual immunotherapy
  • New perspectives for immunotherapy

ASTHMA AND ATOPY IN CHILDHOOD

  • Global burden of pediatric asthma
  • Anti-IgE and pediatric asthma
  • Allergy as a skin barrier disease
  • Inflammation as a systemic problem
  • Role of early allergy in childhood asthma development
  • Anaphylaxis in children and infants
  • Congenital cystic lung lesions
  • Respiratory infection and wheezing in early life
  • Early allergy vs lung function development
  • Anti-inflammatory treatment of airways: current and future
  • Role of LABA and leukotriene-receptor antagonist in childhood asthma
  • Obstructive sleep disordered breathing
  • Severe asthma in children
  • Chronic cough
  • Nose and lung interactions: importance of nose when treating asthma
  • Imaging the airway
  • Insights in oral tolerance
  • Food allergy: towards clinical practice guidelines
  • Cow’s milk allergy prevention and treatment
  • Atopic eczema in children: novel approaches
  • Use of biomarkers to personalize asthma therapy
  • Immunotherapy in children: SCIT or SLIT?
  • Novel forms of immunotherapy
  • Drug allergy in children

ASTHMA AND PREGNANCY

ASTHMA AND QUALITY OF LIFE

STRESS AND ASTHMA

ASTHMA AND SPORTS

TOBACCO SMOKE AND ASTHMA

ATOPY AND ASTHMA

ALLERGY, ASTHMA AND VACCINES

ASTHMA AND RHINITIS

ASTHMA AND ATOPIC DERMATITIS

FOOD ALLERGY AND ASTHMA

COPD

  • Etiology of COPD
  • Pathogenesis of COPD
  • Genetic background of COPD
  • Biomarkers in COPD
  • Oxidative and nitrative stress: control of cell function in COPD
  • Airway inflammation in COPD
  • Risk factors of COPD
  • Smoking and COPD
  • Exacerbation of COPD
  • Epidemiology of COPD
  • COPD: environmental factors and socioeconomic impact
  • Patient breathlessness in COPD
  • COPD: the role of primary care
  • COPD management
  • COPD: a systemic disease affecting the muscles manage¬ment on dynamic hyperinflation during exercise in COPD
  • Systemic manifestations and comorbidities of COPD
  • Modern methods of therapy in COPD
  • Treatment of intermittent COPD
  • COPD in childhood
  • Modern methods of rehabilitation in COPD
  • COPD guidelines
WORLD IMMUNOPATHOLOGY ORGANIZATION
Phone: +7 (495) 735-1414; Fax: +7 (495) 735-1441; E-mail: info@wipocis.org
Политика конфиденциальности | Разработка сайта |  Управление сайтом: CMS.SSPRO